EdgarLookup

SOUTH DAKOTA SOYBEAN PROCESSORS LLC — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that SOUTH DAKOTA SOYBEAN PROCESSORS LLC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
2.1%
Return on Assets
Net income ÷ assets

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2015 Dec 31, 2013 $0 Mar 23, 2016
FY2014 Dec 31, 2012 $0 Mar 25, 2015
FY2013 Dec 31, 2011 $72.0K Mar 21, 2014

Revenue

Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $503.82M Mar 31, 2026
FY2025 Dec 31, 2024 $554.42M Mar 31, 2026
FY2025 Dec 31, 2023 $703.15M Mar 31, 2026
FY2024 Dec 31, 2022 $721.53M Mar 28, 2025
FY2023 Dec 31, 2021 $590.15M Mar 22, 2024
FY2022 Dec 31, 2020 $415.03M Mar 30, 2023
FY2021 Dec 31, 2019 $371.28M Apr 27, 2022
FY2020 Dec 31, 2018 $391.76M Mar 31, 2021
FY2019 Dec 31, 2017 $375.76M Mar 18, 2020
FY2018 Dec 31, 2016 $377.93M Mar 20, 2019

Revenue (Net Sales)

Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.

Fiscal Year Period End Value Filed
FY2018 Dec 31, 2018 $391.44M Mar 20, 2019
FY2018 Dec 31, 2017 $375.26M Mar 20, 2019
FY2018 Dec 31, 2016 $377.93M Mar 20, 2019
FY2017 Dec 31, 2015 $367.56M Mar 21, 2018
FY2016 Dec 31, 2014 $434.84M Mar 22, 2017
FY2015 Dec 31, 2013 $468.83M Mar 23, 2016
FY2014 Dec 31, 2012 $411.99M Mar 25, 2015
FY2013 Dec 31, 2011 $397.23M Mar 21, 2014
FY2012 Dec 31, 2010 $285.19M Mar 25, 2013
FY2011 Dec 31, 2009 $263.50M Mar 30, 2012

Gross Profit

Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $24.70M Mar 31, 2026
FY2025 Dec 31, 2024 $29.39M Mar 31, 2026
FY2025 Dec 31, 2023 $78.42M Mar 31, 2026
FY2024 Dec 31, 2022 $73.42M Mar 28, 2025
FY2023 Dec 31, 2021 $33.47M Mar 22, 2024
FY2022 Dec 31, 2020 $19.25M Mar 30, 2023
FY2021 Dec 31, 2019 $14.80M Apr 27, 2022
FY2020 Dec 31, 2018 $29.16M Mar 31, 2021
FY2019 Dec 31, 2017 $11.61M Mar 18, 2020
FY2018 Dec 31, 2016 $14.10M Mar 20, 2019

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $17.74M Mar 31, 2026
FY2025 Dec 31, 2024 $20.32M Mar 31, 2026
FY2025 Dec 31, 2023 $70.45M Mar 31, 2026
FY2024 Dec 31, 2022 $67.46M Mar 28, 2025
FY2023 Dec 31, 2021 $28.01M Mar 22, 2024
FY2022 Dec 31, 2020 $15.58M Mar 30, 2023
FY2021 Dec 31, 2019 $10.98M Apr 27, 2022
FY2020 Dec 31, 2018 $25.88M Mar 31, 2021
FY2019 Dec 31, 2017 $6.77M Mar 18, 2020
FY2018 Dec 31, 2016 $12.59M Mar 20, 2019

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $17.45M Mar 31, 2026
FY2025 Dec 31, 2024 $23.33M Mar 31, 2026
FY2025 Dec 31, 2023 $71.93M Mar 31, 2026
FY2024 Dec 31, 2022 $67.75M Mar 28, 2025
FY2023 Dec 31, 2021 $28.88M Mar 22, 2024
FY2022 Dec 31, 2020 $15.43M Mar 30, 2023
FY2021 Dec 31, 2019 $11.18M Apr 27, 2022
FY2020 Dec 31, 2018 $25.33M Mar 31, 2021
FY2019 Dec 31, 2017 $8.40M Mar 18, 2020
FY2018 Dec 31, 2016 $10.66M Mar 20, 2019

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 ($38.92M) Mar 31, 2026
FY2025 Dec 31, 2024 $58.40M Mar 31, 2026
FY2025 Dec 31, 2023 $128.89M Mar 31, 2026
FY2024 Dec 31, 2022 $27.43M Mar 28, 2025
FY2023 Dec 31, 2021 $18.02M Mar 22, 2024
FY2022 Dec 31, 2020 $14.21M Mar 30, 2023
FY2021 Dec 31, 2019 ($3.35M) Apr 27, 2022
FY2020 Dec 31, 2018 $30.48M Mar 31, 2021
FY2019 Dec 31, 2017 $7.40M Mar 18, 2020
FY2018 Dec 31, 2016 $18.15M Mar 20, 2019

Capital Expenditures (Capex)

Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $202.16M Mar 31, 2026
FY2025 Dec 31, 2024 $175.70M Mar 31, 2026
FY2025 Dec 31, 2023 $104.27M Mar 31, 2026
FY2024 Dec 31, 2022 $7.75M Mar 28, 2025
FY2023 Dec 31, 2021 $13.44M Mar 22, 2024
FY2022 Dec 31, 2020 $4.65M Mar 30, 2023
FY2021 Dec 31, 2019 $10.07M Apr 27, 2022
FY2020 Dec 31, 2018 $8.03M Mar 31, 2021
FY2019 Dec 31, 2017 $14.49M Mar 18, 2020
FY2018 Dec 31, 2016 $7.07M Mar 20, 2019

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $842.78M Mar 31, 2026
FY2025 Dec 31, 2024 $541.89M Mar 31, 2026
FY2024 Dec 31, 2023 $422.73M Mar 28, 2025
FY2023 Dec 31, 2022 $311.20M Mar 22, 2024
FY2022 Dec 31, 2021 $245.29M Mar 30, 2023
FY2021 Dec 31, 2020 $225.82M Apr 27, 2022
FY2020 Dec 31, 2019 $167.06M Mar 31, 2021
FY2019 Dec 31, 2018 $144.85M Mar 18, 2020
FY2018 Dec 31, 2017 $123.22M Mar 20, 2019
FY2017 Dec 31, 2016 $121.24M Mar 21, 2018

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $8.35M Mar 31, 2026
FY2025 Dec 31, 2024 $39.59M Mar 31, 2026
FY2024 Dec 31, 2023 $72.91M Mar 28, 2025
FY2023 Dec 31, 2022 $866.7K Mar 22, 2024
FY2022 Dec 31, 2021 $833.7K Mar 30, 2023
FY2021 Dec 31, 2020 $3.65M Apr 27, 2022
FY2021 Dec 31, 2019 $624.7K Apr 27, 2022
FY2021 Dec 31, 2018 $7.20M Apr 27, 2022
FY2020 Dec 31, 2017 $683.5K Mar 31, 2021
FY2019 Dec 31, 2016 $11.65M Mar 18, 2020

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $253.84M Mar 31, 2026
FY2024 Dec 31, 2024 $69.22M Mar 28, 2025
FY2023 Dec 31, 2023 $0 Mar 22, 2024
FY2022 Dec 31, 2022 $8.85M Mar 30, 2023
FY2021 Dec 31, 2021 $16.90M Apr 27, 2022
FY2020 Dec 31, 2020 $17.51M Mar 31, 2021
FY2019 Dec 31, 2019 $16.60M Mar 18, 2020
FY2018 Dec 31, 2018 $665.2K Mar 20, 2019
FY2017 Dec 31, 2017 $5.18M Mar 21, 2018
FY2016 Dec 31, 2016 $785.4K Mar 22, 2017

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 0 Mar 31, 2026
FY2025 Dec 31, 2024 0 Mar 31, 2026
FY2025 Dec 31, 2023 2 Mar 31, 2026
FY2024 Dec 31, 2022 2 Mar 28, 2025
FY2023 Dec 31, 2021 0 Mar 22, 2024
FY2022 Dec 31, 2020 0 Mar 30, 2023

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 0 Mar 31, 2026
FY2025 Dec 31, 2024 0 Mar 31, 2026
FY2025 Dec 31, 2023 2 Mar 31, 2026
FY2024 Dec 31, 2022 2 Mar 28, 2025
FY2023 Dec 31, 2021 0 Mar 22, 2024
FY2022 Dec 31, 2020 0 Mar 30, 2023